Strengthen Handling Of Infections And Against Antimicrobial Resistance, Sysmex Indonesia Launches Flagship Hematology Tool, XR-Series

JAKARTA - PT Sysmex Indonesia (Sysmex Indonesia), an in-vitro diagnostic (IVD) company that has been operating in Indonesia for more than two decades, launched its latest innovation and technology of flagship automatic hematology instruments called, XR-Series, in an event that took place at Spiegel Café & Resto Semarang, on Wednesday, October 23.

As one of the leading companies in the diagnostic industry, Sysmex Indonesia continues to show its commitment to improving the quality of health services in Indonesia. The launch of the latest XR-Series hematological instrument is Sysmex's response to global health challenges, particularly related to antimicrobial control and resistance (AMR), which is an increasingly pressing health issue. XR-Series is designed to support faster, more accurate, and efficient infectional screening and treatment processes, thus enabling health practitioners to carry out early detection and more precise handling.

Emilani Nababan, President Director of PT Sysmex Indonesia, emphasized the importance of technological innovation in facing national health challenges.

"The Indonesian Sysmex team has always been committed to supporting Indonesia's health care system through relevant innovations. The launch of the automatic hematology analysis of the Sysmex XR-Series flagship is not only about presenting the latest technology, but is also part of our contribution in preparing Indonesia Gold 2045 where public health is a top priority. This contribution Sysmex realized through screening better examination and diagnosis of hematology," said Emilani Nababan.

XR-Series is the latest generation to analyze automatic hematology, continuing the success of the previous series, XN-Series, which has been widely known in laboratories around the world and is trusted by various laboratories and hospitals in Indonesia. With its innovative technology, XR-Series is designed to increase work capacity, shorten waiting times, and become a more efficient hematology solution for clinical laboratories in Indonesia.

Equipped with cutting-edge features, XR-Series strengthens laboratory capabilities in providing faster and more accurate examination results, especially in handling infectious patients and combating the threat of antimicrobial resistance.

The launch of XR-Series further strengthens Sysmex Indonesia's mission to present innovative health solutions and ensure sustainable health services in Indonesia. XR-Series is expected to be able to increase the role of laboratories in the implementation of comprehensive infections and provide more optimal health services for the people of Indonesia.